Target intelligence / Profile preview

Host sialylated glycan receptors

Molecular classification
Receptor, Glycan, Cell surface glycoconjugate
01

Overview

Host sialylated glycan receptors are terminal carbohydrate structures, typically N-acetylneuraminic acid (Neu5Ac), found on the surface of glycoproteins and glycolipids of mammalian cells (Varki, A. 2008, Trends in Molecular Medicine). These receptors play a fundamental role in biological processes such as cell-cell recognition, immune response modulation via Siglecs, and stabilization of protein conformations (Crocker, P. R., et al. 2007, Nature Reviews Immunology). In the context of infectious diseases, they serve as the primary attachment points for numerous pathogens, including influenza viruses, parainfluenza viruses, and certain coronaviruses (Skehel, J. J., & Wiley, D. C. 2000, Annual Review of Biochemistry). The specificity of the linkage between sialic acid and the underlying galactose (e.g., alpha 2-3 or alpha 2-6) often determines host range and tissue tropism for respiratory viruses. Therapeutic interventions targeting these receptors include sialidases like DAS181, which enzymatically remove the sialic acid residues to prevent viral entry, and glycomimetics that compete for viral binding sites (Moss, R. B., et al. 2012, Expert Opinion on Investigational Drugs). Because of their ubiquitous nature, targeting these receptors requires careful consideration of potential impacts on normal cellular signaling and immune homeostasis.

Other names
Sialic acid receptorsSialoglycansSialylated glycoconjugatesNeu5Ac receptorsSialic acid-containing glycansHost cell sialic acids
02

Mechanism of action

Enzymatic cleavage of terminal sialic acid residues from host cell surfaces to prevent viral attachment and entry; competitive inhibition of viral hemagglutinin binding to host glycans.

03

Biological functions

Cell-cell recognitionImmune regulationPathogen attachmentSignal transductionCell adhesion
04

Disease associations

InfectionCancerInflammationAutoimmune disease
05

Safety considerations

Potential for mucosal irritationDisruption of endogenous sialic acid-mediated signalingImmune system modulation via Siglec interferenceShort duration of action for enzymatic therapies
06

Interacting drugs

DAS181 (Fludase)

4 more in the full profile.

07

Biomarkers

Alpha 2-3 linked sialic acid expressionAlpha 2-6 linked sialic acid expressionSiglec-7 expressionSiglec-9 expression

Beyond the preview

Go deeper on Host sialylated glycan receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host sialylated glycan receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call